Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2006 1
2008 1
2009 1
2011 2
2012 1
2015 1
2017 2
2018 1
2019 1
2021 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock.
Barthélémy O, Rouanet S, Brugier D, Vignolles N, Bertin B, Zeitouni M, Guedeney P, Hauguel-Moreau M, Hage G, Overtchouk P, Akin I, Desch S, Vicaut E, Zeymer U, Thiele H, Montalescot G. Barthélémy O, et al. Among authors: vignolles n. J Am Coll Cardiol. 2021 Jan 19;77(2):144-155. doi: 10.1016/j.jacc.2020.11.025. J Am Coll Cardiol. 2021. PMID: 33446307 Free article. Clinical Trial.
Investigator Versus Core Laboratory Evaluation of Coronary Flow and Related Mortality in the CULPRIT-SHOCK Trial.
Zeitouni M, Barthélémy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Hage G, Overtchouk P, Brugier D, Vignolles N, Kerneis M, Silvain J, Collet JP, Vicaut E, Desch S, Zeymer U, Thiele H, Montalescot G. Zeitouni M, et al. Among authors: vignolles n. Circ Cardiovasc Interv. 2019 Oct;12(10):e008296. doi: 10.1161/CIRCINTERVENTIONS.119.008296. Epub 2019 Oct 14. Circ Cardiovasc Interv. 2019. PMID: 31607157 Clinical Trial. No abstract available.
Thrombus composition in sudden cardiac death from acute myocardial infarction.
Silvain J, Collet JP, Guedeney P, Varenne O, Nagaswami C, Maupain C, Empana JP, Boulanger C, Tafflet M, Manzo-Silberman S, Kerneis M, Brugier D, Vignolles N, Weisel JW, Jouven X, Montalescot G, Spaulding C. Silvain J, et al. Among authors: vignolles n. Resuscitation. 2017 Apr;113:108-114. doi: 10.1016/j.resuscitation.2017.01.030. Epub 2017 Feb 14. Resuscitation. 2017. PMID: 28212919
Vorapaxar in the secondary prevention of atherothrombotic events.
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators. Morrow DA, et al. N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24. N Engl J Med. 2012. PMID: 22443427 Free article. Clinical Trial.
Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy.
Overtchouk P, Barthélémy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Zeitouni M, Silvain J, Collet JP, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G; Collaborators. Overtchouk P, et al. EuroIntervention. 2021 Feb 5;16(15):e1237-e1244. doi: 10.4244/EIJ-D-20-00139. EuroIntervention. 2021. PMID: 32624460 Free PMC article. Clinical Trial.
Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention.
Brieger D, Collet JP, Silvain J, Landivier A, Barthélémy O, Beygui F, Bellemain-Appaix A, Mercadier A, Choussat R, Vignolles N, Costagliola D, Montalescot G. Brieger D, et al. Among authors: vignolles n. Catheter Cardiovasc Interv. 2011 Feb 1;77(2):182-90. doi: 10.1002/ccd.22674. Catheter Cardiovasc Interv. 2011. PMID: 20578166
16 results